Minimum Offer of Guaranteed Workshare Still Not Enough to Enforce Teaming Agreement
Client Alert | 1 min read | 08.31.20
In Futrend Tech., Inc. v. MicroHealth LLC, a Virginia state court considered “an all too familiar tale” of a government contractor attempting to enforce a teaming agreement, and once again refused to do so. This case involved an incumbent prime contractor, Futrend, who teamed with an 8(a) small business, MicroHealth, to bid on the follow-on contract set aside for 8(a) businesses. MicroHealth was ultimately awarded the contract, but the relationship between the parties broke down while negotiating a subcontract contemplated by their teaming agreement. Futrend brought suit against MicroHealth alleging, inter alia, breach of that agreement, which promised approximately 49% of the workshare under the awarded contract.
Citing the “well-settled” law in Virginia that contractual provisions that “merely set out agreements to negotiate future subcontracts” are unenforceable, the court refused to enforce the agreement. The court noted the parties’ acknowledgement that the “minimum offer” required under the agreement established a floor legal obligation, but found it to be “illusory and indefinite.” While the agreement “guaranteed” workshare of “approximately 49%” of the awarded contract, the court explained that the use of the word “approximate” indicated a degree of indefiniteness. Given these “uncertain” legal obligations, the court held that the teaming agreement was unenforceable. In addition to the breach of contract count, the court also rejected all other claims flowing from the teaming agreement, including breach of non-solicitation provision, tortious interference, misappropriation of trade secrets, conspiracy, and unjust enrichment.
Contacts
Insights
Client Alert | 7 min read | 06.26.26
Federal Roundup: Updates for PBMs and Medicare Advantage Organizations
In June 2026, federal regulators and lawmakers continued their efforts to improve drug affordability through targeted reforms. These recent developments will primarily impact pharmaceutical manufacturers, managed care organizations, and pharmacy benefit managers (PBM) serving Medicare Part D program members. PBMs, Medicare Advantage organizations, and Part D sponsors should monitor these changes in the interest of maintaining compliance and providing input on regulatory proposals that may influence their business operations or compensation structures in the future.
Client Alert | 6 min read | 06.26.26
Client Alert | 4 min read | 06.25.26
Twin Executive Orders Seek to Spur Quantum Leap in Technology and Cybersecurity
Client Alert | 7 min read | 06.24.26




